Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-14FDA Approved: ELTROMBOPAG — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original application for eltrombopag olamine from Novadoz Pharmaceuticals LLC.
-
FDA approval · 2026-01-14FDA Approved: ELTROMBOPAG — Original Application (Zydus Pharmaceuticals USA Inc.)
Zydus Pharmaceuticals USA Inc. received FDA approval for an original application of eltrombopag (generic), a thrombopoietin receptor agonist…
-
FDA approval · 2026-01-14FDA Approved: ELTROMBOPAG OLAMINE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's eltrombopag olamine as an Original Application (ANDA), making a generic version of eltrombopag …
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia [Phase 3]
A Phase 3 trial is evaluating the safety and efficacy of subcutaneous Efgartigimod in adults with primary immune thrombocytopenia. The study…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia [Phase 1]
This entry reports on a Phase 1 clinical trial evaluating the optimal dose of zanubrutinib for adults with immune thrombocytopenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase [Phase 2]
Phase 2 trial evaluating aspirin in patients with immune thrombocytopenia and cardiovascular disease has completed.
-
CLINICAL_TRIALS other · 2025-12-31Clinical Trial Update: French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
A French registry study enrolling adults with immune thrombocytopenia and autoimmune hemolytic anemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia
This clinical trial update outlines research into the role of genetic expression of interleukin-1β and interleukin-33 in the pathogenesis of…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]
A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 clinical trial evaluating lusutrombopag for immune thrombocytopenia has completed, assessing its potential to raise platelet counts …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia [Phase 1, Phase 2]
Clinical trial update for CM336 in relapsed or refractory autoimmune cytopenia, including immune thrombocytopenia, autoimmune hemolytic anem…
-
CLINICAL_TRIALS other · 2025-12-12Clinical Trial Update: Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia [Phase 2, Phase 3]
This clinical trial is evaluating the combination of avatrombopag with all-trans retinoic acid for primary immune thrombocytopenia in Phase …
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
This entry describes a national multicenter retrospective real-world study in China to assess the treatment status of newly diagnosed and pe…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia [NA]
This clinical trial investigates the combination of Romiplostim N01 with Rituximab for primary immune thrombocytopenia that is refractory to…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 2]
A Phase 2 clinical trial is evaluating an anti-CD38 antibody for treating pediatric primary immune thrombocytopenia (ITP). The study is curr…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP) [EARLY_Phase 1]
PRG-1801 is being evaluated for safety and efficacy in patients with recurrent or refractory primary immune thrombocytopenia, in an early-ph…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia [Phase 2]
A Phase 2 study evaluating VLX-1005 versus placebo for suspected heparin-induced thrombocytopenia was terminated.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Severe Immune Cytopenia Registry Www.Sic-reg.Org
This entry provides a completed update on the Severe Immune Cytopenia Registry (SIC-reg), sponsored by the Medical University of Graz, cover…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia [Phase 1]
A Phase I clinical trial of SHR-2173 injections in patients with primary immune thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 study of rilzabrutinib in adults with immune thrombocytopenia has completed, with results posted.
-
CLINICAL_TRIALS withdrawal · 2025-11-10Clinical Trial Update: Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias [Phase 2]
An extension study of fostamatinib (Syk inhibitor) for posttransplant immune-mediated cytopenias has been withdrawn, including autoimmune he…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan [Phase 3]
This clinical trial update covers rilzabrutinib for adults with immune thrombocytopenia. It notes that a Phase 3 study conducted in Japan ha…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children
This clinical trial update describes a planned study to evaluate safety and efficacy of romiplostim for chronic immune thrombocytopenia in c…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: OM336 in Autoimmune Cytopenias [Phase 1]
Ouro Medicines reports a Phase 1 clinical trial of OM336 for autoimmune cytopenias, including warm and cold autoimmune hemolytic anemia and …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: An Exploratory Study of Golidocitinib in Adult Patients With ITP [Phase 1, Phase 2]
An exploratory, early-phase clinical trial of golidocitinib for immune thrombocytopenia is planned and currently not recruiting.